Companies: 10,795·Total market cap: $144.5T
Medline Inc.

Medline Inc.

MDLNNASDAQHealthcare● Active
$33.61
$-0.84(-2.44%)
Market Cap$28.4B
P/E Ratio—
52W High$50.876
52W Low$32.815
SEC Filings

Medline Inc. (MDLN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0002046386 · MDLN · NASDAQ · as of Jun 8, 2026

Filing snapshot

123
Total Filings
8-K
Latest Form
2026-06-02
Most Recent
2025
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0002046386 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-25
Fiscal Year End
Feb 25, 2026
Accession No.
0002046386-26-000009
Primary Document
mdln-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0002046386 · Accession 0002046386-26-000009

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-06
View 10-Q on SEC
8-KCurrent Report
8-K
2026-06-02Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-06-02
View
424B4424B4
424B4
2026-05-26
View
EFFECTEFFECT
EFFECT
2026-05-21
View
S-1MEFS-1MEF
S-1MEF
2026-05-21
View
S-1IPO Registration Statement
S-1
2026-05-20
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-07
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-06
View
10-QQuarterly Report
10-Q
2026-05-06
View
8-KCurrent Report
8-K
2026-05-06
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-01
View
ARSARS
ARS
2026-04-23
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-23
View
DEF 14AProxy Statement
FORM DEF 14A
2026-04-23
View
DRSDRS
DRS
2026-04-17
View
Showing 1–15 of 78 filingsForm 4 / 144 hidden· 123 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0002046386  |  Exchange: NASDAQ · Healthcare

Medline Inc. (NASDAQ: MDLN) has submitted 123 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2025. As a Healthcare sector company with CIK 0002046386, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Medline Inc.'s most comprehensive regulatory disclosure. The most recent Medline Inc. 10-K was filed on 2026-02-25 for fiscal year ending 2026. Historical MDLN 10-K annual reports are available from 2024 through 2026.

Investors researching Medline Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
RMD SEC Filings →COO SEC Filings →AVTR SEC Filings →BLCO SEC Filings →NTSK SEC Filings →LMAT SEC Filings →KMTS SEC Filings →LMRI SEC Filings →
→ MDLN Financials→ MDLN Earnings→ MDLN Insider Trades

Frequently Asked Questions

MDLN SEC Filings · 8 questions

Medline Inc. (MDLN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 123 filings and access original documents at no cost. Medline Inc.'s CIK is 0002046386.

MDLN SEC filingsMedline Inc. SEC documentsfind MDLN 10-K